Strides Pharma Science Limited has informed the Exchange regarding a press release dated September 23, 2023, titled "Strides receives USFDA approval for Icosapent Ethyl Capsules".
Strides Pharma Science Limited has informed the Exchange regarding a press release dated September 23, 2023, titled "Strides receives USFDA approval for Icosapent Ethyl Capsules".